Thomas D. Penning
Impact in
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
- Organic Chemistry top 1%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
Papers in
- Oncology 23
- PARP inhibition in cancer therapy 14
- Cytokine Signaling Pathways and Interactions 5
-
- Cancer therapeutics and mechanisms 6
- DNA Repair Mechanisms 5
- Co-authors
- Karen Seibert (4 shared papers)James K. Gierse (5 shared papers)Peter C. Isakson (4 shared papers)Roderick A. Stegeman (2 shared papers)William C. Stallings (2 shared papers)Anna M. Stevens (2 shared papers)Ravi G. Kurumbail (2 shared papers)Joseph J. McDonald (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (16 papers)Journal of Medicinal Chemistry (5 papers)Journal of the American Chemical Society (3 papers)Clinical Cancer Research (2 papers)Tetrahedron Letters (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Thomas D. Penning
51 papers receiving 3.3k citations
Thomas D. Penning's Hit Papers
Peers
Comparison fields: 5 of 118
- Pharmacology 1.1k
- Organic Chemistry 1.5k
- Oncology 808
- Biochemistry 226
- Toxicology 82
Countries citing papers authored by Thomas D. Penning
This map shows the geographic impact of Thomas D. Penning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Penning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Penning more than expected).
Fields of papers citing papers by Thomas D. Penning
This network shows the impact of papers produced by Thomas D. Penning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Penning. The network helps show where Thomas D. Penning may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas D. Penning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents Hit paper breakdown → | 1996 | 1579 |
| 2 | 2008 | 218 | |
| 3 | 1999 | 145 | |
| 4 | 2011 | 139 | |
| 5 | 1990 | 129 | |
| 6 | 2009 | 112 | |
| 7 | 2009 | 99 | |
| 8 | 2009 | 94 | |
| 9 | 1988 | 80 | |
| 10 | 2009 | 78 | |
| 11 | 2009 | 75 | |
| 12 | 2008 | 61 | |
| 13 | 2008 | 52 | |
| 14 | 2008 | 42 | |
| 15 | 2001 | 41 | |
| 16 | 1984 | 40 | |
| 17 | 1986 | 38 | |
| 18 | 2009 | 31 | |
| 19 | Small-molecule PARP modulators--current status and future therapeutic potential. | 2010 | 30 |
| 20 | 2002 | 29 |
About Thomas D. Penning
Thomas D. Penning is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Pharmacology and Physiology, having authored 52 papers that have together received 3.5k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (14 papers), Asthma and respiratory diseases (12 papers), Inflammatory mediators and NSAID effects (9 papers), Synthesis and biological activity (7 papers), Cancer therapeutics and mechanisms (6 papers), DNA Repair Mechanisms (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). The work is most often cited by research in Pharmacology (1.1k citations), Organic Chemistry (1.5k citations), Oncology (808 citations), Biochemistry (226 citations) and Toxicology (82 citations). Thomas D. Penning has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Karen Seibert, James K. Gierse, Peter C. Isakson, Roderick A. Stegeman, William C. Stallings, Anna M. Stevens, Ravi G. Kurumbail, Joseph J. McDonald, Carl R. Johnson and Eric F. Johnson. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of the American Chemical Society, Clinical Cancer Research and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.